A detailed history of Ubs Group Ag transactions in Evogene Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 62,495 shares of EVGN stock, worth $39,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,495
Previous 56,005 11.59%
Holding current value
$39,371
Previous $47,000 2.13%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.7 - $0.98 $4,543 - $6,360
6,490 Added 11.59%
62,495 $46,000
Q4 2023

Feb 09, 2024

BUY
$0.47 - $0.88 $9,400 - $17,600
20,000 Added 55.55%
56,005 $47,000
Q3 2023

Nov 09, 2023

BUY
$0.58 - $1.41 $4,049 - $9,844
6,982 Added 24.06%
36,005 $21,000
Q2 2023

Aug 11, 2023

BUY
$0.56 - $1.2 $4,490 - $9,621
8,018 Added 38.17%
29,023 $31,000
Q1 2023

May 12, 2023

SELL
$0.59 - $0.86 $22 - $32
-38 Reduced 0.18%
21,005 $13,000
Q4 2022

Feb 08, 2023

BUY
$0.61 - $0.78 $2,135 - $2,730
3,500 Added 19.95%
21,043 $14,000
Q3 2022

Nov 10, 2022

BUY
$0.73 - $1.27 $2,217 - $3,858
3,038 Added 20.94%
17,543 $15,000
Q2 2022

Aug 10, 2022

SELL
$0.75 - $1.33 $15,945 - $28,275
-21,260 Reduced 59.44%
14,505 $11,000
Q1 2022

May 16, 2022

SELL
$1.09 - $1.83 $20,456 - $34,343
-18,767 Reduced 34.41%
35,765 $47,000
Q4 2021

Feb 14, 2022

BUY
$1.63 - $2.83 $65,283 - $113,344
40,051 Added 276.58%
54,532 $90,000
Q3 2021

Nov 15, 2021

SELL
$2.45 - $3.45 $50,903 - $71,680
-20,777 Reduced 58.93%
14,481 $38,000
Q2 2021

Aug 13, 2021

BUY
$3.3 - $5.02 $25,043 - $38,096
7,589 Added 27.43%
35,258 $121,000
Q1 2021

May 12, 2021

BUY
$4.29 - $9.94 $956 - $2,216
223 Added 0.81%
27,669 $139,000
Q4 2020

Feb 11, 2021

SELL
$2.41 - $5.63 $246,352 - $575,504
-102,221 Reduced 78.83%
27,446 $129,000
Q3 2020

Nov 12, 2020

SELL
$0.97 - $4.08 $180,809 - $760,520
-186,402 Reduced 58.98%
129,667 $514,000
Q2 2020

Jul 31, 2020

SELL
$0.92 - $1.29 $957,895 - $1.34 Million
-1,041,191 Reduced 76.71%
316,069 $316,000
Q1 2020

May 01, 2020

SELL
$0.75 - $1.81 $10,187 - $24,585
-13,583 Reduced 0.99%
1,357,260 $1.6 Million
Q4 2019

Feb 14, 2020

SELL
$1.29 - $1.69 $53,513 - $70,106
-41,483 Reduced 2.94%
1,370,843 $2.08 Million
Q3 2019

Nov 14, 2019

SELL
$1.37 - $1.7 $47,396 - $58,813
-34,596 Reduced 2.39%
1,412,326 $2.23 Million
Q2 2019

Aug 14, 2019

BUY
$1.4 - $2.47 $54,087 - $95,425
38,634 Added 2.74%
1,446,922 $2.33 Million
Q1 2019

May 14, 2019

BUY
$1.83 - $2.38 $162,417 - $211,232
88,753 Added 6.73%
1,408,288 $2.58 Million
Q4 2018

Feb 14, 2019

BUY
$1.98 - $3.01 $30,070 - $45,712
15,187 Added 1.16%
1,319,535 $2.61 Million
Q3 2018

Nov 14, 2018

BUY
$2.6 - $3.14 $43,726 - $52,808
16,818 Added 1.31%
1,304,348 $4.06 Million
Q2 2018

Aug 14, 2018

BUY
$2.84 - $3.29 $33,333 - $38,614
11,737 Added 0.92%
1,287,530 $3.68 Million
Q1 2018

May 15, 2018

SELL
$3.15 - $4.16 $7,994 - $10,558
-2,538 Reduced 0.2%
1,275,793 $4.05 Million
Q4 2017

Feb 14, 2018

BUY
$3.07 - $4.68 $155,584 - $237,177
50,679 Added 4.13%
1,278,331 $3.92 Million
Q3 2017

Nov 14, 2017

BUY
$4.24 - $5.06 $331,644 - $395,783
78,218 Added 6.8%
1,227,652 $5.45 Million
Q2 2017

Aug 14, 2017

BUY
N/A
96,897 Added 9.21%
1,149,434 $5.82 Million
Q1 2017

Nov 14, 2017

BUY
N/A
1,052,537
1,052,537 $5.63 Million

Others Institutions Holding EVGN

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $26M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.